| Literature DB >> 29673361 |
F Weijers1, C Veldhoven1, C Verhagen1, K Vissers1, Y Engels2.
Abstract
BACKGROUND: In our aging society, palliative care should be a standard component of health care. However, currently it is only provided to a small proportion of patients, mostly to those with cancer, and restricted to the terminal phase. Many general practitioners (GPs) say that one of their most significant challenges is to assess the right moment to start anticipatory palliative care. The "Surprise Question" (SQ1: "Would I be surprised if this patient were to die in the next 12 months"?), if answered with "no", is an easy tool to apply in identifying patients in need of palliative care. However, this tool has a low specificity. Therefore, the aim of our pilot study was to determine if adding a second, more specific "Surprise Question" (SQ2: "Would I be surprised if this patient is still alive after 12 months"?) in case SQ1 is answered in the negative, prompts GPs to plan for anticipatory palliative care.Entities:
Keywords: General practitioner; Identifying tool; Palliative care; RADIANT; Surprise question
Mesh:
Year: 2018 PMID: 29673361 PMCID: PMC5909217 DOI: 10.1186/s12904-018-0312-6
Source DB: PubMed Journal: BMC Palliat Care ISSN: 1472-684X Impact factor: 3.234
Questions asked to the GPs regarding palliative care provision
| 1. Which aspects trigger you in general to start palliative care? (groups 1-3)* (2missing) |
| 2. Do you think the Surprise Question, ‘Would you be surprised if this patient were to die within 12 months? ‘ would be helpful to identify patients in need of palliative care? (group 2)* (1 missing) |
| 3. Is this Surprise Question applicable in daily practice? What are your concerns /barriers to apply them? (group 2)* (1 missing) |
| 4. Do you think the second Surprise Question, in addition to the first SQ, would be of use in identifying patients in need of palliative care? (group 3)* (1 missing) |
| 5. Are these two Surprise Questions applicable in daily practice? What are your concerns/barriers to apply them? (group 3) (1 missing) |
*study group(s) that received this question
Baseline characteristics
| Characteristic | Group 1 | Group 2 | Group 3 | Non participantsa |
|---|---|---|---|---|
| N | 9 | 10 | 9 | 42c |
| Age mean | 48 | 45 | 53 | 59 |
| Male gender n (%) | 5 (56) | 3 (30) | 6 (67) | 19 (45) |
| Type of practice n (%) | ||||
| Single-handed practice | 1 (11) | 0 (0) | 3 (33) | 4 (10) |
| Two-man practice | 3 (33) | 6 (60) | 2 (22) | 12 (29) |
| Group practice | 5 (56) | 4 (40) | 4 (44) | 26 (62) |
| Years of working experience as GP, mean | 16.7 | 14.5 | 22.5 | 20.5 |
| GP trainer n (%) | 2 (22) | 6 (60) | 6 (67) | 15 (36) |
| Specialised GPb n (%) | 0 (0) | 1 (10) | 0 (0) | 1 (2) |
| Estimated number of palliative patients / year, mean | 5.1 | 6.4 | 6.7 | 5.7 |
| Interest in palliative care (0: not at all; 10 extremely interested), mean | 7.9 | 8.3 | 7.9 | 8.0 |
| Self-assessed expertise in palliative care (0: no expertise; 10 extremely high expertise), mean | 6.7 | 7.1 | 7.7 | 7.3 |
aGPs who were invited to participate in the study, but did not give informed consent (97) or gave informed consent but did not complete the vignette questionnaire (5)
bA GP that has followed an extensive additional course in palliative care or in elderly care
cGPs who provided socio-demographics and palliative care related data
RADIANT scoring table
| Item | Score | Provenancea |
|---|---|---|
| 1. Discusses patient’s personal aspects of quality of life | 1 | x, y |
| 2. Discusses how to achieve patient’s personal goals | 1 | q, x, y |
| 3. Adheres to the patient’s preferences | 1 | q, y |
| Provides attention to the following dimensions: | q, x, y | |
| 4. Somatic problems | ||
| 5. Social context and finances | ||
| 6. Caregiving and activities of daily living | ||
| 7. Existential and psychological issues | ||
| 8. Involves other disciplines, including consultation team palliative care | 1 | y |
| 9. Provides palliative care alongside disease-oriented care | 1 | x |
| Discusses advance care planning aspects: | ||
| 10. Hospital admissions | 1 | q, z |
| 11. Antibiotics use | 1 | q, z |
| 12. CPR policy | 1 | q, y, z |
| 13. Mechanical ventilation | 1 | q, z |
| 14. Treatment limitations – not specified | 1 | q, y |
| 15. Dying scenario’s | 1 | q, y |
| 16. Life prolonging treatments (e.g. artificial feeding and i.v. fluids) | 1 | q, z |
| 17. Preferences for end-of-life care (e.g. palliative sedation, euthanasia) | 1 | q, y, z |
| 18. Preferred place of death | 1 | q, y, z |
| 19. Writes assignment for the out-of-hours GP cooperative | 1 | q |
| 20. Involves family and loved-ones in care planning | 1 | q, x, y |
| 21. Provides care to family and loved-ones | 1 | x, y |
| Maximum score | 21 |
aprovenance, q Royal Dutch Medical Association [26], x WHO definition of palliative care [3], y Pallialine [24], z Thuisarts [25]
Fig. 1Flowchart study participants. Legend: -
Answers on SQ1a and SQ2b and RADIANT scoresc per groupd and per vignette
| Vignette | Group 2e | RADIANT score group 2 mean | Group 3f | RADIANT score group 3 mean |
|---|---|---|---|---|
| Ag | 10 SQ1 ‘no’ | 6.0 | 5 SQ1 ‘no’ & SQ2 ‘yes’ | 5.0 |
| 4 SQ1 ‘no’ & SQ2 ‘no’ | 1.5 | |||
| Bh | 10 SQ1 ‘no’ | 5.8 | 9 SQ1 ‘no’ & SQ2 ‘yes’ | 5.0 |
| Ci | 9 SQ1 ‘no’ | 4.0 | 5 SQ1 ‘no’ & SQ2 ‘yes’ | 4.6 |
| 1 missing | 3 SQ1 ‘no’ & SQ2 ‘no’ | 4.0 | ||
| 1 missing | ||||
| Dj | 5 SQ1 ‘no’ | 3.0 | 2 SQ1 ‘no’ & SQ2 ‘yes’ | 3.0 |
| 4 SQ1 ‘yes’ | 1.8 | 3 SQ1 ‘no’ & SQ2 ‘no’ | 2.3 | |
| 3 SQ1 ‘yes’ & SQ2 ‘no’ | 0 | |||
| 1 missing |
aSQ1: Would I be surprised if this patient were to die in the next 12 months?
bSQ2: Would I be surprised if this patient is still alive after 12 months?
cRADIANT score: see Table 3
d only group 2 and group 3 are represented here, as group 1 did not receive any SQ
egroup 2: received only SQ1 after each vignette
fgroup 3: received SQ1 and SQ2 after each vignette
gvignette A: advanced organ failure
hvignette B: end-stage metastatic pancreatic cancer
ivignette C: frailty
jvignette D: recently diagnosed metastatic colon cancer
Mean cumulative RADIANT scoresa per group, per vignette and per SQ answer combination
| Vignette | Group 1 | Group 2 | Group 3 | Mean | ||
|---|---|---|---|---|---|---|
| SQ1c all answers | SQ1 ‘no’ | SQ1 all answers | SQ1 ‘no’ & SQ2d ‘yes’ | |||
| Ae | 4.6 | 6.0 | 6.0 | 3.4 | 5.0 | 4.7 |
| Bf | 5.9 | 5.8 | 5.8 | 5.0 | 5.0 | 5.6 |
| Cg | 4.6 | 4.0 | 4.0 | 4.4 | 4.6 | 4.3 |
| Dh | 2.9 | 2.7 | 3.0 | 1.6 | 3.0 | 2.4 |
| Mean | 4.5 | 4.6 | 4.7 | 3.6 | 4.4 | |
aRADIANT score: see Table 3
bsome missing data: in both group 2 and group 3 one GP did not fill out vignettes C and D
cSQ1: Would I be surprised if this patient were to die in the next 12 months?
dSQ2: Would I be surprised if this patient is still alive after 12 months?
evignette A: advanced organ failure
fvignette B: end-stage metastatic pancreatic cancer
gvignette C: frailty
hvignette D: recently diagnosed metastatic colon cancer